[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ES8101552A1 - Clofibric and nicotinic acid esters - Google Patents

Clofibric and nicotinic acid esters

Info

Publication number
ES8101552A1
ES8101552A1 ES488345A ES488345A ES8101552A1 ES 8101552 A1 ES8101552 A1 ES 8101552A1 ES 488345 A ES488345 A ES 488345A ES 488345 A ES488345 A ES 488345A ES 8101552 A1 ES8101552 A1 ES 8101552A1
Authority
ES
Spain
Prior art keywords
cycloalkyl
hydrogen
clofibric
acid esters
nicotinic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES488345A
Other languages
Spanish (es)
Other versions
ES488345A0 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merz and Co GmbH and Co KG
Original Assignee
Merz and Co GmbH and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merz and Co GmbH and Co KG filed Critical Merz and Co GmbH and Co KG
Publication of ES488345A0 publication Critical patent/ES488345A0/en
Publication of ES8101552A1 publication Critical patent/ES8101552A1/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79Acids; Esters
    • C07D213/80Acids; Esters in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Novel compounds of the formula < IMAGE > wherein R is 3-pyridinyl or 2-(4- chlorophenoxy)-2-methyl-propyl R<1> is hydrogen, C5-14 cycloalkyl, (C5-14 cycloalkyl)methyl, (C5-14 cycloalkyl)carbonyl, (C5-14 cycloalkyl)acetyl, 1-adamantyl, 1- adamantylmethyl, 1-adamantylcarbonyl, 1-adamantylacetyl, cumyl, p-chlorobenzoyl, piperidino or 2- pyrimidinyl and R<2> is hydrogen, -(CH2)4-, halogen, C1-6 alkyl, cycloalkyl, methoxy, ethoxy, trifluoromethyl or nitro provided that R<2> is C1-6 cycloalkyl or -(CH2)4- when R<1> is hydrogen or a pharmaceutically acceptable acid addition salts thereof may be used in the treatment of hyperlipidemias.
ES488345A 1979-02-08 1980-02-07 Clofibric and nicotinic acid esters Expired ES8101552A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2904757 1979-02-08

Publications (2)

Publication Number Publication Date
ES488345A0 ES488345A0 (en) 1980-12-16
ES8101552A1 true ES8101552A1 (en) 1980-12-16

Family

ID=6062456

Family Applications (1)

Application Number Title Priority Date Filing Date
ES488345A Expired ES8101552A1 (en) 1979-02-08 1980-02-07 Clofibric and nicotinic acid esters

Country Status (22)

Country Link
JP (1) JPS55129245A (en)
AR (1) AR228251A1 (en)
AT (1) AT374797B (en)
AU (1) AU532208B2 (en)
BE (1) BE881626A (en)
CA (1) CA1135689A (en)
CH (1) CH644092A5 (en)
DK (1) DK152360C (en)
ES (1) ES8101552A1 (en)
FR (1) FR2448532A1 (en)
GB (1) GB2041937B (en)
GR (1) GR73905B (en)
HU (1) HU182099B (en)
IE (1) IE49385B1 (en)
IL (1) IL59337A (en)
IT (1) IT1141197B (en)
MX (1) MX6377E (en)
NL (1) NL8000826A (en)
PL (1) PL123379B1 (en)
SE (1) SE450381B (en)
SG (1) SG51185G (en)
YU (1) YU33880A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2221681A (en) * 1988-01-22 1990-02-14 Kh Nii Endokrinolog I Khim Undecylic ether n-chlorophenoxyisobutyric acid and a pharmaceutical preparation for treating hyperlipemia based on it

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3175M (en) * 1963-06-25 1965-03-08 Analyses Et De Rech S Biolog M New chemical compounds with peripheral vasodilating action.
DE2352012A1 (en) * 1972-11-01 1974-05-09 Ciba Geigy Ag NEW ALIPHATICALLY SUBSTITUTED ARYLCHALCOGENO-HYDROCARBON DERIVATIVES AND THE PROCESS FOR THEIR PRODUCTION
ES438246A1 (en) * 1975-06-04 1977-01-16 Alter Sa Process for purifying the mixed ester, ethylene glycol 1-(2-p-chlorophenoxy)-2-methylpropionate nicotinate
JPS57102866A (en) * 1980-12-19 1982-06-26 Kyorin Pharmaceut Co Ltd Nicotinic acid derivative and its preparation

Also Published As

Publication number Publication date
AU5535580A (en) 1980-08-14
JPS55129245A (en) 1980-10-06
DK152360C (en) 1988-08-01
JPS6126993B2 (en) 1986-06-23
IT8019782A0 (en) 1980-02-08
GB2041937A (en) 1980-09-17
CH644092A5 (en) 1984-07-13
FR2448532A1 (en) 1980-09-05
MX6377E (en) 1985-05-23
ATA70380A (en) 1983-10-15
BE881626A (en) 1980-08-08
DK53680A (en) 1980-08-09
AT374797B (en) 1984-05-25
PL221888A1 (en) 1980-10-20
DK152360B (en) 1988-02-22
SE8000962L (en) 1980-08-09
FR2448532B1 (en) 1984-12-14
SE450381B (en) 1987-06-22
GB2041937B (en) 1983-04-13
CA1135689A (en) 1982-11-16
AR228251A1 (en) 1983-02-15
YU33880A (en) 1983-06-30
NL8000826A (en) 1980-08-12
PL123379B1 (en) 1982-10-30
HU182099B (en) 1983-12-28
GR73905B (en) 1984-05-21
IE800236L (en) 1980-08-08
IE49385B1 (en) 1985-10-02
SG51185G (en) 1986-01-24
ES488345A0 (en) 1980-12-16
IT1141197B (en) 1986-10-01
IL59337A (en) 1984-10-31
AU532208B2 (en) 1983-09-22

Similar Documents

Publication Publication Date Title
NO308845B1 (en) New benzylpyrimidines
CA2015034A1 (en) Piperazine derivatives
HUT65868A (en) Process for producing ortosubstituted benzoyl-guanidine derivatives and pharmaceutical preparations containing them
NO862621D0 (en) PROCEDURE FOR PREPARING PYRIDON CARBOXYLIC ACID DERIVATIVES.
FI925801A (en) PIPERIDYL SUBSTITUERADE INDOLER
EP0369263A3 (en) Preparations for the topical treatment of skin diseases
DK26289A (en) USE OF 1,4-DISUBSTITUTED PIPERIDINYL FOR THE PREPARATION OF A PHARMACEUTICAL PREPARATION FOR TREATING INSOMNIA
NO913391L (en) PROCEDURE FOR THE PREPARATION OF NEW HETRAZEPINOID ACIDAMIDS.
YU182581A (en) Process for preparing new 5,10-dihydro-11h-dibenzo-(b,e)(1,4)diazepine-11-ones substituted in position 5
DE3856501D1 (en) Sleep improver
ATE19875T1 (en) PYRIDINECARBONATE, PROCESS FOR THEIR PREPARATION AND USE AS A MEDICINAL PRODUCT.
AU1976083A (en) Furan derivatives
ES8101552A1 (en) Clofibric and nicotinic acid esters
DE3164741D1 (en) 2-(4-(diphenylmethylene)-1-piperidinyl)-acetic acids and their amides, their preparation and pharmaceutical preparations containing them
NO955263L (en) N-substituted azaheterocyclic carboxylic acids and esters thereof
ES8506620A1 (en) Pyrrole-2-acetylamino acid derivatives.
ATE92461T1 (en) ACTIVE AGAINST CEREBRAL INSUFFICIENCY COMPOUNDS.
ES8106143A1 (en) Cinnamoylpiperidinobutyrophenone antipsychotic agents
DE3778152D1 (en) DERIVATIVES OF 5- (2- (1-PYRROLIDINYL) -AETHOXY) -P-CYMEN, METHOD FOR THE PRODUCTION THEREOF AND MEDICINAL PRODUCTS CONTAINING THESE DERIVATIVES.
ES8106144A1 (en) Aroylethenylpiperidinobutyrophenone antipsychotic agents
GB2000767A (en) Therapeutic propylamine derivatives
EG19053A (en) Branched-chain alkyl esters of 2-(4-(2-piperidiono-ethoxy)-benzoyl)-benzoic acid, processes for their preparation and their use as spasmolytic agents
JPS5219637A (en) Preparation of novel biscarboxylic acid esters
ES8101066A1 (en) 4-(4-Quinolylpropyl)piperidine derivatives and pharmaceuticals containing them.
JPS5430162A (en) 2-aminomethyl-5-phenyloxazoles and their pharmaceutically acceptable acid salts

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970519